Clamp-crush Technique Versus Harmonic Scalpel in Living Donor Hepatectomy

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

The purpose of this study is to determine whether clamp-crush technique for liver parenchymal transection is as safe as Harmonic scalpel device. outcomes will include: perioperative mortality, surgery-related complications, blood loss, amount of blood loss during hepatectomy, operating time, transection speed, markers of liver parenchymal injury and hospital stay.

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT05047406` - Bacillus Clausii in Liver Transplantation	Phase 2
Completed	`NCT03174327` - Evaluation of Hepatic Rigidity by Ultrasonic Impulse Elastography in Liver Transplant Patients	N/A
Completed	`NCT01388387` - Pharmacogenetic Study of Tacrolimus in Hepatic Transplant (CYPTAC'H)	N/A

NCT number	NCT02853981
Study type	Interventional
Source	Mansoura University
Contact
Status	Completed
Phase	Phase 2/Phase 3
Start date	January 2015
Completion date	September 2016

Clamp-crush Technique Versus Harmonic Scalpel in Living Donor Hepatectomy — KK_HS

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms